BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen L, Hu B, Song X, Wang L, Ju M, Li Z, Zhou C, Zhang M, Wei Q, Guan Q, Jiang L, Chen T, Wei M, Zhao L. m6A RNA Methylation Regulators Impact Prognosis and Tumor Microenvironment in Renal Papillary Cell Carcinoma. Front Oncol 2021;11:598017. [PMID: 33796449 DOI: 10.3389/fonc.2021.598017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Guo L, Yang H, Zhou C, Shi Y, Huang L, Zhang J. N6-Methyladenosine RNA Modification in the Tumor Immune Microenvironment: Novel Implications for Immunotherapy. Front Immunol 2021;12:773570. [PMID: 34956201 DOI: 10.3389/fimmu.2021.773570] [Reference Citation Analysis]
2 Wu J, Wei Y, Miao C, Wang S, Wang X, Wang Z, Wang J. Essential m6A Methylation Regulator HNRNPC Serves as a Targetable Biomarker for Papillary Renal Cell Carcinoma. Journal of Oncology 2022;2022:1-29. [DOI: 10.1155/2022/9411692] [Reference Citation Analysis]
3 Du M, Peng Y, Li Y, Sun W, Zhu H, Wu J, Zong D, Wu L, He X. MYC-activated RNA N6-methyladenosine reader IGF2BP3 promotes cell proliferation and metastasis in nasopharyngeal carcinoma. Cell Death Discov 2022;8:53. [PMID: 35136045 DOI: 10.1038/s41420-022-00844-6] [Reference Citation Analysis]
4 Liu J, Zhou Z, Ma L, Li C, Lin Y, Yu T, Wei JF, Zhu L, Yao G. Effects of RNA methylation N6-methyladenosine regulators on malignant progression and prognosis of melanoma. Cancer Cell Int 2021;21:453. [PMID: 34446007 DOI: 10.1186/s12935-021-02163-9] [Reference Citation Analysis]